That would be believable if they passed the retest. They were in control of the "procedures" in the second go round and still failed. You have to be in serious denial that there appears to be something critically flawed with the safety of this device after being rejected by the FDA after waiting six years on the first application and now a twice failed cytotoxicity test a year and a half later.
At some point folks need to face reality regarding the incessant BS coming from this company.
News 
Market Data 
Discover 
AI
